MEANTI, RAMONA
 Distribuzione geografica
Continente #
AS - Asia 2.493
NA - Nord America 2.404
EU - Europa 1.971
SA - Sud America 323
AF - Africa 45
OC - Oceania 5
Totale 7.241
Nazione #
US - Stati Uniti d'America 2.340
VN - Vietnam 918
IT - Italia 761
SG - Singapore 627
CN - Cina 401
DE - Germania 362
HK - Hong Kong 262
BR - Brasile 259
RU - Federazione Russa 254
IE - Irlanda 111
GB - Regno Unito 95
SE - Svezia 93
ID - Indonesia 68
FR - Francia 63
IN - India 63
FI - Finlandia 48
CA - Canada 37
KR - Corea 37
PL - Polonia 35
NL - Olanda 26
AR - Argentina 24
JP - Giappone 22
UA - Ucraina 21
MX - Messico 19
CH - Svizzera 18
BD - Bangladesh 17
BE - Belgio 17
TR - Turchia 17
ZA - Sudafrica 17
ES - Italia 13
EC - Ecuador 12
AT - Austria 11
TW - Taiwan 11
CZ - Repubblica Ceca 10
DK - Danimarca 9
IQ - Iraq 8
EG - Egitto 7
PY - Paraguay 7
CO - Colombia 6
PK - Pakistan 6
RO - Romania 6
KE - Kenya 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DZ - Algeria 4
EE - Estonia 4
GR - Grecia 4
SN - Senegal 4
TN - Tunisia 4
BO - Bolivia 3
CU - Cuba 3
IR - Iran 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
PE - Perù 2
PS - Palestinian Territory 2
UZ - Uzbekistan 2
BH - Bahrain 1
CR - Costa Rica 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LI - Liechtenstein 1
PH - Filippine 1
SC - Seychelles 1
TH - Thailandia 1
Totale 7.241
Città #
Ann Arbor 593
Singapore 412
Ho Chi Minh City 299
Ashburn 285
Hong Kong 260
Frankfurt am Main 259
Milan 240
Hanoi 226
Chandler 128
Beijing 114
Dallas 114
Dublin 110
New York 88
Wilmington 84
Los Angeles 75
Hefei 74
Fairfield 67
Jakarta 64
Santa Clara 51
Rome 41
Princeton 36
Seattle 35
Buffalo 34
London 34
Munich 34
Seoul 32
São Paulo 32
Da Nang 29
Moscow 29
Haiphong 27
Woodbridge 25
Chicago 24
Biên Hòa 22
Council Bluffs 22
Helsinki 22
Ha Long 21
Houston 21
Kent 21
Tokyo 21
Warsaw 21
Nuremberg 20
Shanghai 19
Can Tho 18
Cambridge 17
Monza 17
Romola 17
Turku 17
Denver 16
Orem 16
Pune 16
Brussels 15
Dearborn 14
Quận Bình Thạnh 14
Boardman 13
Brooklyn 13
Toronto 13
Altamura 12
Hải Dương 12
Poplar 12
Fremont 11
Paris 11
Thái Nguyên 11
Turin 11
Bắc Giang 10
Bắc Ninh 10
Carate Brianza 10
Guangzhou 10
Lawrence 10
Rio de Janeiro 10
San Francisco 10
Stockholm 10
Vũng Tàu 10
Ankara 9
Mexico City 9
Quận Một 9
Quận Phú Nhuận 9
Sacramento 9
Dong Ket 8
Genoa 8
Johannesburg 8
Lappeenranta 8
Salerno 8
Taichung 8
Vinh 8
Andover 7
Atlanta 7
Bari 7
Bresso 7
Hangzhou 7
Ninh Bình 7
Pavia 7
Phoenix 7
Phủ Lý 7
Quận Sáu 7
The Dalles 7
Zurich 7
Baldissero Torinese 6
Boston 6
Chiavari 6
Huế 6
Totale 4.760
Nome #
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 451
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 412
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 399
Growth hormone secretagogues and the regulation of calcium signaling in muscle 395
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 350
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 309
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 300
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 299
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 270
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 266
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 265
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 244
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 242
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 232
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 226
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 223
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 219
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 213
Selected growth hormone secretagogues (GHS) as disease modifiers in models of neurodegenerative diseases and amyotrophic lateral sclerosis: a proof-of-concept study 213
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 191
The role of androgens in women's health and wellbeing 174
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 169
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections? 158
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 157
Exploring the role of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease: the impact of MSC preconditioning on targeted therapeutic efficacy 145
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 139
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 136
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 131
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 110
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 102
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 96
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 94
Role of nutrition in degenerative disease 80
Symptom management, adherence to therapy, and filling the gaps of medical cannabis therapy: a qualitative study on the importance of nursing consultations for fibromyalgia patients 42
Totale 7.452
Categoria #
all - tutte 23.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 0 0 0 0 0 57 47 48 45 34 58 64
2021/2022479 64 33 42 45 33 34 12 16 12 41 47 100
2022/2023801 92 156 98 70 44 109 20 69 41 29 34 39
2023/2024606 30 39 36 59 72 116 82 39 40 25 20 48
2024/20251.771 76 98 100 147 148 133 149 60 129 236 186 309
2025/20262.978 1.053 541 361 477 443 103 0 0 0 0 0 0
Totale 7.452